OGI Fundamental Analysis - ORGANIGRAM GLOBAL INC

Fundamental Rating

OGI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 34 industry peers in the Pharmaceuticals industry. The financial health of OGI is average, but there are quite some concerns on its profitability. OGI is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

OGI had positive earnings in the past year.

In the past year OGI has reported a negative cash flow from operations.

OGI had negative earnings in each of the past 5 years.

OGI had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

With an excellent Return On Assets value of 3.14%, OGI belongs to the best of the industry, outperforming 82.35% of the companies in the same industry.

OGI has a Return On Equity of 4.32%. This is in the better half of the industry: OGI outperforms 79.41% of its industry peers.

		Industry Rank	Sector Rank
ROA	3.14%
ROE	4.32%
ROIC	N/A

ROA(3y)-32.3%

ROA(5y)-30.36%

ROE(3y)-36.4%

ROE(5y)-36.38%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Profit Margin value of 8.70%, OGI belongs to the best of the industry, outperforming 82.35% of the companies in the same industry.

OGI does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	8.7%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

OGI does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, OGI has more shares outstanding

The number of shares outstanding for OGI has been increased compared to 5 years ago.

OGI has a worse debt/assets ratio than last year.

2.2 Solvency

OGI has an Altman-Z score of -0.25. This is a bad value and indicates that OGI is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -0.25, OGI is in the better half of the industry, outperforming 61.76% of the companies in the same industry.

OGI has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.

With a decent Debt to Equity ratio value of 0.11, OGI is doing good in the industry, outperforming 64.71% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.11
Debt/FCF	N/A
Altman-Z	-0.25

ROIC/WACCN/A

WACC8.51%

2.3 Liquidity

OGI has a Current Ratio of 3.42. This indicates that OGI is financially healthy and has no problem in meeting its short term obligations.

OGI has a better Current ratio (3.42) than 88.24% of its industry peers.

OGI has a Quick Ratio of 1.90. This is a normal value and indicates that OGI is financially healthy and should not expect problems in meeting its short term obligations.

OGI's Quick ratio of 1.90 is fine compared to the rest of the industry. OGI outperforms 73.53% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.42
Quick Ratio	1.9

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

OGI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 101.81%, which is quite impressive.

The Revenue has grown by 26.93% in the past year. This is a very strong growth!

OGI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.73% yearly.

EPS 1Y (TTM)101.81%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%226.92%

Revenue 1Y (TTM)26.93%

Revenue growth 3Y26.37%

Revenue growth 5Y14.73%

Sales Q2Q%74.34%

3.2 Future

Based on estimates for the next years, OGI will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.09% on average per year.

OGI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.97% yearly.

EPS Next Y49.21%

EPS Next 2Y38.52%

EPS Next 3Y29.86%

EPS Next 5Y19.09%

Revenue Next Year48.22%

Revenue Next 2Y31.13%

Revenue Next 3Y26.16%

Revenue Next 5Y18.97%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 31.33, OGI can be considered very expensive at the moment.

Compared to the rest of the industry, the Price/Earnings ratio of OGI indicates a somewhat cheap valuation: OGI is cheaper than 76.47% of the companies listed in the same industry.

The average S&P500 Price/Earnings ratio is at 26.32. OGI is around the same levels.

OGI is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	31.33
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as OGI's earnings are expected to grow with 29.86% in the coming years.

PEG (NY)0.64

PEG (5Y)N/A

EPS Next 2Y38.52%

EPS Next 3Y29.86%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for OGI!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ORGANIGRAM GLOBAL INC

TSX:OGI (6/17/2025, 7:00:00 PM)

1.88

-0.06 (-3.09%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Earnings (Last)05-12 2025-05-12/bmo

Earnings (Next)08-11 2025-08-11

Inst Owners5.59%

Inst Owner ChangeN/A

Ins Owners2.47%

Ins Owner ChangeN/A

Market Cap251.69M

Analysts77.78

Price Target2.84 (51.06%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)258.42%

Min EPS beat(2)-400%

Max EPS beat(2)916.83%

EPS beat(4)2

Avg EPS beat(4)131.47%

Min EPS beat(4)-400%

Max EPS beat(4)916.83%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)1

Avg Revenue beat(2)-3.11%

Min Revenue beat(2)-12.23%

Max Revenue beat(2)6%

Revenue beat(4)3

Avg Revenue beat(4)0.09%

Min Revenue beat(4)-12.23%

Max Revenue beat(4)6%

Revenue beat(8)4

Avg Revenue beat(8)-1.86%

Revenue beat(12)6

Avg Revenue beat(12)-0.65%

Revenue beat(16)9

Avg Revenue beat(16)1.46%

PT rev (1m)-1.77%

PT rev (3m)-1.77%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)3.94%

Revenue NQ rev (3m)3.94%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0.13%

Valuation

		Industry Rank	Sector Rank
PE	31.33
Fwd PE	N/A
P/S	1.3
P/FCF	N/A
P/OCF	N/A
P/B	0.64
P/tB	0.88
EV/EBITDA	N/A

EPS(TTM)0.06

EY3.19%

EPS(NY)-0.03

Fwd EYN/A

FCF(TTM)-0.72

FCFYN/A

OCF(TTM)-0.63

OCFYN/A

SpS1.45

BVpS2.92

TBVpS2.13

PEG (NY)0.64

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	3.14%
ROE	4.32%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	8.7%
GM	N/A
FCFM	N/A

ROA(3y)-32.3%

ROA(5y)-30.36%

ROE(3y)-36.4%

ROE(5y)-36.38%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0.36

Health

		Industry Rank	Sector Rank
Debt/Equity	0.11
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	77.7%
Cap/Sales	5.74%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.42
Quick Ratio	1.9
Altman-Z	-0.25

F-Score3

WACC8.51%

ROIC/WACCN/A

Cap/Depr(3y)118.74%

Cap/Depr(5y)166.77%

Cap/Sales(3y)18.54%

Cap/Sales(5y)32.36%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)101.81%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%226.92%

EPS Next Y49.21%

EPS Next 2Y38.52%

EPS Next 3Y29.86%

EPS Next 5Y19.09%

Revenue 1Y (TTM)26.93%

Revenue growth 3Y26.37%

Revenue growth 5Y14.73%

Sales Q2Q%74.34%

Revenue Next Year48.22%

Revenue Next 2Y31.13%

Revenue Next 3Y26.16%

Revenue Next 5Y18.97%

EBIT growth 1Y8.94%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year134.97%

EBIT Next 3Y49.25%

EBIT Next 5Y29.71%

FCF growth 1Y-7.54%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-100.66%

OCF growth 3YN/A

OCF growth 5YN/A

ORGANIGRAM GLOBAL INC (OGI.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens